Amanote Research
Register
Sign In
34. Demonstration of Systemic Exon 45-55 Multiple Skipping in Dystrophic Mdx52 Mice
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35838-5
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2012
Authors
Unknown
Publisher
Elsevier BV
Related search
Proteomic Profiling of Antisense-Induced Exon Skipping Reveals Reversal of Pathobiochemical Abnormalities in Dystrophic MDX Diaphragm
Proteomics
Biochemistry
Molecular Biology
111. Exons 45-55 Skipping of Human Dystrophin Transcripts Using Cocktail Antisense Oligonucleotides
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Antisense Oligo-Mediated Multiple Exon Skipping in a Dog Model of Duchenne Muscular Dystrophy
Methods in Molecular Biology
Genetics
Molecular Biology
Polyquaternium-Mediated Delivery of Morpholino Oligonucleotides for Exon-Skipping in Vitro and in MDX Mice
Drug Delivery
Medicine
Pharmaceutical Science
Exon 32 Skipping of Dysferlin Rescues Membrane Repair in Patients’ Cells
Journal of Neuromuscular Diseases
Neurology
The Silent Mutation Nucleotide 744 G → A, Lys172Lys, in Exon 6 of BRCA2 Results in Exon Skipping
Breast Cancer Research and Treatment
Cancer Research
Oncology
Exon Skipping: A First in Class Strategy for Duchenne Muscular Dystrophy
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
Dual Exon Skipping in Myostatin and Dystrophin for Duchenne Muscular Dystrophy
BMC Medical Genomics
Genetics
Antisense-Induced Exon Skipping and Synthesis of Dystrophin in the MDX Mouse
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
